http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2799893-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16e694a83e0a87e09d92f0c1de5b4704
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-28
filingDate 2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d1c20410e40a381c5e3125cfab4fb9
publicationDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2799893-A1
titleOfInvention Novel derivatives of mesalazine, process for their preparation and their use in the treatment of intestinal inflammatory diseases
abstract The present invention refers to the compounds corresponding to the following general formula (I): (I) wherein: R = C4-C8 alkanoyl; and X = NH-R1 where R1 = H, or an amine protecting group; and/or the pharmaceutically acceptable salts thereof. Preferred compounds according to the present invention are represented by the following formula (Ia): (Ia) wherein: R = C4-C8 alkanoyl; and/or the pharmaceutically acceptable salts thereof. In a preferred embodiment, an object of the present invention is to provide 5-amino-2- (butyryloxy)benzoic acid and/or the pharmaceutically acceptable salts thereof, preferably hydrochloride salt. A further object of the present invention is represented by the use of the compounds of formula (la), in particular 5-amino-2-(butyryloxy)benzoic acid and/or pharmaceutically acceptable salts thereof, as a medicament and by the use thereof for the treatment of intestinal inflammatory diseases. The present invention also regards the synthesis processes to obtain such compounds and some intermediate compounds of said synthesis processes.
priorityDate 2010-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451349547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409796636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453706522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54761684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408394011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410627549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54761683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20443148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450477660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86722321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450319599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412037371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 75.